Results 1 to 10 of about 15,266 (342)

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future. [PDF]

Front Oncol, 2022
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms.
Zhang Z, Li D, Yun H, Liu W, Chai K, Tong J, Zeng T, Gao Z, Xie Y.   +8 more
europepmc   +6 more sources

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges. [PDF]

Front Oncol, 2023
At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then induces ...
Su P, Zhang M, Kang X.
europepmc   +6 more sources

Microbiome in urologic neoplasms: focusing on tumor immunity. [PDF]

Front Immunol
Urological tumors are an important disease affecting global human health, and their pathogenesis and treatment have been the focus of medical research.
Zou J, Xu B, Gao H, Luo P, Chen T, Duan H.   +5 more
europepmc   +5 more sources

Updates in Histologic Grading of Urologic Neoplasms [PDF]

Archives of Pathology & Laboratory Medicine, 2020
Context.—Tumor histology offers a composite view of the genetic, epigenetic, proteomic, and microenvironmental determinants of tumor biology. As a marker of tumor histology, histologic grading has persisted as a highly relevant factor in risk stratification and management of urologic neoplasms (ie, renal cell carcinoma, prostatic adenocarcinoma, and ...
Travis Rice‐Stitt, Aida Valencia‐Guerrero, Kristine M. Cornejo, Chin‐Lee Wu   +3 more
openalex   +4 more sources

The expression of apolipoproteina1 and its correlation with infiltration of urologic neoplasm [PDF]

Translational Cancer Research, 2020
To explore the differential expression of apolipoproteinA1 (APOA1) in urologic neoplasm patient compared with controls, as well as investigates whether APOA1 correlated with infiltration of urologic neoplasm.A total of 59 tissue sections of surgically-resected urologic neoplasm and 6 cases of normal tissue sections were collected.
Huihui Hu, Bei Gong, Man Zhang
openalex   +4 more sources

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists [PDF]

Human Pathology, 2017
Renal oncocytoma and chromophobe renal cell carcinoma have been long recognized as distinct tumors; however, it remains unknown if uniform diagnostic criteria are used to distinguish these tumor types in practice. A survey was distributed to urologic pathologists regarding oncocytic tumors. Responses were received from 17 of 26 invitees. Histologically,
Sean R. Williamson, Ramya Gadde, Kiril Trpkov, Michelle S. Hirsch, John R. Srigley, Victor E. Reuter, Liang Cheng, Lakshmi P. Kunju, Ravi Barod, Craig Rogers, Brett Delahunt, Ondřej Hes, John N. Eble, Ming Zhou, Jesse K. McKenney, Guido Martignoni, Stewart Fleming, David J. Grignon, Holger Moch, Nilesh Gupta   +19 more
openalex   +6 more sources

The Role of Exenterative Surgery in Advanced Urological Neoplasms

Current Urology, 2020
Pelvic exenterative surgery is both complex and challenging, especially in the setting of locally recurrent disease. In recent decades, improved surgical techniques have facilitated more extensive resection of both locally advanced and recurrent pelvic malignancies, but its role in urological cancer surgery is highly selective.
Colla Cunneen, Michael E. Kelly, Gregory J. Nason, Éanna J. Ryan, Ben Creavin, D. C. Winter   +5 more
openalex   +4 more sources

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists

Virchows Archiv
AbstractOncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging entities, is necessary. Emerging entities recently described include eosinophilic solid and cystic renal cell
Sambit K. Mohanty, Anandi Lobo, Shilpy Jha, Ankur R. Sangoi, Mahmut Akgul, Kiril Trpkov, Ondřej Hes, Rohit Mehra, Michelle S. Hirsch, Holger Moch, Steven C. Smith, Rajal B. Shah, Liang Cheng, Mohammed A. Amin, Jonathan I. Epstein, Anil V. Parwani, Brett Delahunt, Sangeeta Desai, Christopher G. Przybycin, Claudia Manini, Daniel Luthringer, Deepika Sirohi, Deepika Jain, Divya Midha, Ekta Jain, Fiona Maclean, Giovanna A. Giannico, Gladell P. Paner, Guido Martignoni, Hikmat Al‐Ahmadie, Jesse K. McKenney, John R. Srigley, José I. López, Lakshmi P. Kunju, Lisa Browning, Manju Aron, Maria M. Picken, Maria Tretiakova, Ming Zhou, Mukund Sable, Naoto Kuroda, Niharika Pattnaik, Nilesh Gupta, Priya Rao, Samson W. Fine, Pritinanda Mishra, Amit Kumar Adhya, Bijal Kulkarni, Mallika Dixit, Manas Baisakh, Samriti Arora, Sankalp Sancheti, Santosh Menon, Sara E. Wobker, Satish K. Tickoo, Seema Kaushal, Shailesh Soni, Shivani Kandukuri, Shivani Sharma, Suvradeep Mitra, Victor E Reuter, Vipra Malik, Vishal Rao, Ying‐Bei Chen, Sean R. Williamson   +64 more
  +6 more sources

Prognostic effect of pretreatment serum gamma-glutamyl transferase in urological malignancies: a systematic review and meta-analysis. [PDF]

Front Oncol
BackgroundThis study aimed ​​to investigate​​ the association between pretreatment serum gamma-glutamyltransferase (GGT) and survival outcomes in patients with urological malignancies, such as urothelial carcinoma (UCa), renal cell carcinoma (RCC), and ...
Song F, Su S, Zhang X, Cui X, Li C, Li S.   +5 more
europepmc   +2 more sources

The Diagnosis of Urological Neoplasm in Dialysis Patients - a Brief Review [PDF]

Medicina Moderna - Modern Medicine, 2017
Mircea Merticariu, Andrei Niculae, Corina-Ioana Merticariu, Ileana Adela Văcăroiu, Flavia Liliana Turcu, Viorel Jinga   +5 more
openalex   +2 more sources